BMO Capital analyst Evan Seigerman lowered the firm’s price target on AbbVie (ABBV) to $208 from $228 and keeps an Outperform rating on ...

The global body contouring treatments market growth forecasted to transform from USD 1.46 billion in 2024 to USD 2.58 billion ...

If you're 18 to 35 (18 to 30 in some countries), come work and travel in Canada through International Experience Canada (IEC)! It's a government program designed to help you gain valuable ...

GSK acquired an experimental therapy from Chimagen Biosciences, paying $300 million upfront for the “T-cell engager” therapy, ...

The foundation donation will go toward construction of UChicago Medicine's $815 million freestanding cancer care center in ...

Q3 2024 Earnings Call Transcript October 30, 2024 AbbVie Inc. beats earnings expectations. Reported EPS is $3, expectations ...

This Ontario listing comes two months after Canada's Drug Agency (formerly CADTH) issued a reimbursement recommendation for VRAYLAR, and just days after AbbVie successfully reached an agreement ...

Macklem said the rate cuts are necessary because the Canadian economy is in a weaker state relative to the U.S. "The economy is growing but it's soft," he said. He added that the policy rate remains ...

AbbVie cautions that these forward-looking statements ... achieving in-play patient leadership across all lines of therapy in the U.S, Japan and Canada. Skyrizi’s U.S. in-play patient share ...

Welcome to the AbbVie third quarter 2024 earnings conference call. [Operator instructions] I would now like to introduce Ms.

Immigrants help grow Canada’s future. According to Statistics Canada, immigrants are making important contribution across every sector of Canada’s economy. As of May 2021, immigrants aged 25 to 54 ...